TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm

GlobeNewswire Inc. Logo GlobeNewswire Inc. By The Schall Law Firm
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm

A class action lawsuit has been filed against DexCom for allegedly making false and misleading statements about its G6 and G7 medical systems, which were changed without FDA authorization and potentially posed health risks to users.

Insights
LRCX   positive

Strong semiconductor industry performance, 123% stock growth in 2025, record revenue and operating margin, increased quarterly earnings


DXCM   negative

The company is accused of making unauthorized changes to medical devices, downplaying health risks, and potentially misleading investors, which led to potential investor damages